Tag: Philips IntelliSite Pathology Solution
Alexi Baidoshvili, a Pathologist at LabPON Discusses the Benefits and Challenges of Digitizing Your Workflow
Webinar date: Wednesday, March 1st 2017, 4.00 PM – 5.00 PM GMT The Laboratory for Pathology East Netherlands Foundation (LabPON) replaced its microscopes with the Philips IntelliSite pathology solution1, becoming the first laboratory in the world to transition to 100% digital diagnosis for all clinical histology cases. As the largest pathology laboratory in the Netherlands, LabPON is […]
Multi-Center Clinical Validation Study by Philips to be Submitted to FDA in Support of Expanded Indications for Use for Philips IntelliSite Digital Pathology Solution in the U.S.
Great news from Philips who announced on October 21st their completion of a glass versus digital concordance study to be submitted to FDA. The press release mentions 2,000 cases with approximately 16,000 reads. The press release goes on to say that the final discordance rate was 1%. Philips will submit the results of the study along […]
Interesting news yesterday from Philips and Genomic Health announcing a collaboration of their technologies. For many years I have thought one of the main drivers for digital pathology adoption in an increasing trend towards personalized, predictive and pre-emptive medicine would be the need for a bridge between morphology and molecular. Often times the paraffin block […]
Largest pathology laboratory in the Netherlands becomes first in the world to complete transition to digital pathology Eindhoven, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) recently announced that the Netherlands-based LabPON has become the first clinical pathology laboratory in the world to have transitioned completely to digital diagnosis. With this shift, all clinical histology cases are now […]